van Vliet E, Melis M, van Ewijk W
Cell Immunol. 1986 Dec;103(2):229-40. doi: 10.1016/0008-8749(86)90086-9.
The effect of injection of a range of doses of dexamethasone on the distribution of T-cell subpopulations and stromal cells in the thymus of BALB/c mice was investigated with flowcytometry and immunohistology. To this purpose we used monoclonal antibodies directed to the T-cell differentiation antigens Thy-1, T200, Lyt-1, Lyt-2, T4, MEL-14, and monoclonal antibodies directed to various classes of stromal cells. Injection of dexamethasone in increasing doses of 5-130 mg/kg body weight gradually leads to a depletion of the cortical thymocyte population, i.e., bright Thy-1 + ve, dull T-200 + ve, bright Lyt-2 + ve, and bright T4 + ve cells. These cortical cells are very dull MEL-14 + and express variable numbers of Lyt-1 molecules. Also the medulla is affected by dexamethasone although to a lesser extent. Dexamethasone injection at 130 mg/kg selects for a dull Thy-1 + ve, bright T-200 + ve, and bright Lyt-1 + ve medullary population. These cells are either T4 + ve Lyt-2-ve or T4-ve Lyt-2 + ve. Under these conditions, MEL-14 + ve cells were no longer present in the cortex but accumulated in medullary perivascular spaces. Staining of sequential sections showed that this particular subpopulation has a typical "helper" phenotype. This observation provides strong evidence that perivascular compartments are an exit pathway for emigrating T cells. The medullary population contains a phenotypically distinct, dexamethasone-sensitive subpopulation. This conclusion is based on two findings: 130 mg/kg dexamethasone depletes the thymus of all but 4% of the thymocytes, which form a much smaller subpopulation than the population of dull Thy-1 + ve cells (amounting to 15% of the total thymocytes). The medulla contains a subpopulation of dull Lyt-2 + ve cells, which are resistant to 20 mg/kg dexamethasone, but depleted by 130 mg/kg. Dexamethasone also has a severe effect on thymic nonlymphoid cells. Even at low doses, dexamethasone induces TR4 + ve cortical epithelial-reticular cells to become spherical ("nurse cell-like") structures, depleted of lymphoid cells. These stromal cells no longer express MHC antigens in a membrane-bound fashion. In contrast, the medullary epithelial cells appear morphologically unaffected even at a dexamethasone dose of 130 mg/kg.
采用流式细胞术和免疫组织学方法,研究了一系列剂量的地塞米松注射对BALB/c小鼠胸腺中T细胞亚群和基质细胞分布的影响。为此,我们使用了针对T细胞分化抗原Thy-1、T200、Lyt-1、Lyt-2、T4、MEL-14的单克隆抗体,以及针对各类基质细胞的单克隆抗体。以5 - 130mg/kg体重递增剂量注射地塞米松,会逐渐导致皮质胸腺细胞群体减少,即明亮的Thy-1阳性、暗淡的T-200阳性、明亮的Lyt-2阳性和明亮的T4阳性细胞减少。这些皮质细胞MEL-14染色非常暗淡,并表达数量可变的Lyt-1分子。髓质也受到地塞米松的影响,尽管程度较小。以130mg/kg剂量注射地塞米松会筛选出暗淡的Thy-1阳性、明亮的T-200阳性和明亮的Lyt-1阳性髓质细胞群体。这些细胞要么是T4阳性Lyt-2阴性,要么是T4阴性Lyt-2阳性。在这些条件下,MEL-14阳性细胞不再存在于皮质中,而是聚集在髓质血管周围间隙。连续切片染色显示,这个特定的亚群具有典型的“辅助性”表型。这一观察结果提供了强有力的证据,表明血管周围区域是迁出T细胞的一条出口途径。髓质细胞群体包含一个表型独特、对地塞米松敏感的亚群。这一结论基于两个发现:130mg/kg地塞米松可使胸腺中除4%的胸腺细胞外全部耗尽,这4%的胸腺细胞形成的亚群比暗淡的Thy-1阳性细胞群体小得多(占胸腺细胞总数的15%)。髓质中包含一个暗淡的Lyt-2阳性细胞亚群,它们对20mg/kg地塞米松有抗性,但会被130mg/kg地塞米松耗尽。地塞米松对胸腺非淋巴细胞也有严重影响。即使在低剂量下,地塞米松也会诱导TR4阳性的皮质上皮网状细胞变成球形(“类滋养细胞”)结构,且淋巴细胞缺失。这些基质细胞不再以膜结合方式表达MHC抗原。相比之下,即使在地塞米松剂量为130mg/kg时,髓质上皮细胞在形态上似乎也未受影响。